Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-10.62	-1456.82	-1316.91
Graham Fair Price	0.00	0.50	0.50
PEG	inf	0.00	< 0.005
Price/Book	10.34	0.90	0.81
Price/Cash Flow	10.34	69.34	62.85
Prices/Earnings	10.34	47.23	42.80
Price/Sales	10.34	109.96	99.65
Price/FCF	10.34	69.34	62.85
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	0.00	0.66	0.66
ROA	0.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	0.00
ROIC	< 0.005	< 0.005	0.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	-0.39	inf
Dividends QOQ	0.06	0.00	inf
EBIT QOQ	88.90	0.00	inf
EPS QOQ	71.00	0.00	inf
FCF QOQ	0.30	0.00	inf
Revenue QOQ	1.56	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	158.49	164.11	3.55
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.02	0.02	0.00
Quick Ratio	15.42	15.56	0.87
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.53	1.53	0.00
Cash	0.07	0.07	0.00
Capex	0.00	0.00	0.00
Free Cash Flow	0.02	0.02	0.00
Revenue	0.01	0.01	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	15.69	15.56	-0.82
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	36.35	36.35	0.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating